200 related articles for article (PubMed ID: 15537354)
1. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Wan Y; Wallinder C; Plouffe B; Beaudry H; Mahalingam AK; Wu X; Johansson B; Holm M; Botoros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2004 Nov; 47(24):5995-6008. PubMed ID: 15537354
[TBL] [Abstract][Full Text] [Related]
2. Development of selective non-peptide angiotensin II type 2 receptor agonists.
Alterman M
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):57-66. PubMed ID: 19880657
[TBL] [Abstract][Full Text] [Related]
3. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
[TBL] [Abstract][Full Text] [Related]
4. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
Wan Y; Wallinder C; Johansson B; Holm M; Mahalingam AK; Wu X; Botros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Hallberg A; Alterman M
J Med Chem; 2004 Mar; 47(6):1536-46. PubMed ID: 14998339
[TBL] [Abstract][Full Text] [Related]
5. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N
Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679
[TBL] [Abstract][Full Text] [Related]
6. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
[TBL] [Abstract][Full Text] [Related]
8. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
Murugaiah AM; Wu X; Wallinder C; Mahalingam AK; Wan Y; Sköld C; Botros M; Guimond MO; Joshi A; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2012 Mar; 55(5):2265-78. PubMed ID: 22248302
[TBL] [Abstract][Full Text] [Related]
9. Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
Mahalingam AK; Wan Y; Murugaiah AM; Wallinder C; Wu X; Plouffe B; Botros M; Nyberg F; Hallberg A; Gallo-Payet N; Alterman M
Bioorg Med Chem; 2010 Jun; 18(12):4570-90. PubMed ID: 20493713
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin Peptides as AT2 Receptor Agonists.
Hallberg M; Sävmarker J; Hallberg A
Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
[TBL] [Abstract][Full Text] [Related]
12. Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential.
Unger T; Dahlöf B
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):75-7. PubMed ID: 19861350
[No Abstract] [Full Text] [Related]
13. Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2006 Oct; 49(20):6133-7. PubMed ID: 17004728
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.
Liu J; Liu Q; Yang X; Xu S; Zhang H; Bai R; Yao H; Jiang J; Shen M; Wu X; Xu J
Bioorg Med Chem; 2013 Dec; 21(24):7742-51. PubMed ID: 24200932
[TBL] [Abstract][Full Text] [Related]
15. Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat.
Ewert S; Sjoberg T; Johansson B; Duvetorp A; Holm M; Fandriks L
Exp Physiol; 2006 Jan; 91(1):191-9. PubMed ID: 16263801
[TBL] [Abstract][Full Text] [Related]
16. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation.
Zhao Y; Foryst-Ludwig A; Bruemmer D; Culman J; Bader M; Unger T; Kintscher U
J Neurochem; 2005 Sep; 94(5):1395-401. PubMed ID: 15992368
[TBL] [Abstract][Full Text] [Related]
18. Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
Wallinder C; Botros M; Rosenström U; Guimond MO; Beaudry H; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
Bioorg Med Chem; 2008 Jul; 16(14):6841-9. PubMed ID: 18599297
[TBL] [Abstract][Full Text] [Related]
19. The past, present and future of angiotensin II type 2 receptor stimulation.
Steckelings UM; Rompe F; Kaschina E; Namsolleck P; Grzesiak A; Funke-Kaiser H; Bader M; Unger T
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):67-73. PubMed ID: 19861348
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of p38 inhibitors via computer-assisted drug design.
Goldberg DR; Hao MH; Qian KC; Swinamer AD; Gao DA; Xiong Z; Sarko C; Berry A; Lord J; Magolda RL; Fadra T; Kroe RR; Kukulka A; Madwed JB; Martin L; Pargellis C; Skow D; Song JJ; Tan Z; Torcellini CA; Zimmitti CS; Yee NK; Moss N
J Med Chem; 2007 Aug; 50(17):4016-26. PubMed ID: 17658737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
